Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7024917
[patent_doc_number] => 20050019311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Flow electroporation chamber and method'
[patent_app_type] => utility
[patent_app_number] => 10/846729
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22286
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10846729
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/846729 | Flow electroporation chamber and method | May 13, 2004 | Abandoned |
Array
(
[id] => 4999709
[patent_doc_number] => 20070042343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Forward mutation assay based on 5-fluorouracil resistance'
[patent_app_type] => utility
[patent_app_number] => 10/554433
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 16077
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554433
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554433 | Forward mutation assay based on 5-fluorouracil resistance | Apr 21, 2004 | Issued |
Array
(
[id] => 6927756
[patent_doc_number] => 20050241013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization'
[patent_app_type] => utility
[patent_app_number] => 10/829081
[patent_app_country] => US
[patent_app_date] => 2004-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1349
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20050241013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10829081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/829081 | Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization | Apr 21, 2004 | Abandoned |
Array
(
[id] => 7468098
[patent_doc_number] => 20040198972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Processes for the preparation of oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/828659
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15646
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828659 | Processes for the preparation of oligonucleotides | Apr 20, 2004 | Abandoned |
Array
(
[id] => 6996262
[patent_doc_number] => 20050136040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Control of gene expression using a complex of an oligonucleotide and a regulatory peptide'
[patent_app_type] => utility
[patent_app_number] => 10/824584
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18645
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10824584
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/824584 | Control of gene expression using a complex of an oligonucleotide and a regulatory peptide | Apr 7, 2004 | Abandoned |
Array
(
[id] => 4866288
[patent_doc_number] => 20080145347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => ' p-Hyde sequences in the Rat'
[patent_app_type] => utility
[patent_app_number] => 10/807517
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 41238
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10807517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/807517 | p-Hyde sequences in the Rat | Mar 23, 2004 | Abandoned |
Array
(
[id] => 5754619
[patent_doc_number] => 20060223768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Regulation of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/549711
[patent_app_country] => US
[patent_app_date] => 2004-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5939
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223768.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549711 | Regulation of gene expression | Mar 16, 2004 | Abandoned |
Array
(
[id] => 7351511
[patent_doc_number] => 20040248841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Poly-DNP-siRNA'
[patent_app_type] => new
[patent_app_number] => 10/801118
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3383
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10801118
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/801118 | Poly-DNP-siRNA | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7318839
[patent_doc_number] => 20040224889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Using polyamide nucleic acid oligomers to engender a biological response'
[patent_app_type] => new
[patent_app_number] => 10/799238
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 26756
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224889.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799238 | Using polyamide nucleic acid oligomers to engender a biological response | Mar 11, 2004 | Abandoned |
Array
(
[id] => 7256997
[patent_doc_number] => 20040259912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Benzine derivatives, process for preparing the same and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/489621
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70856
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489621 | Benzine derivatives, process for preparing the same and use thereof | Mar 11, 2004 | Abandoned |
Array
(
[id] => 7426734
[patent_doc_number] => 20040229831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Compositions and methods for non-parenteral delivery of oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/793497
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30623
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229831.pdf
[firstpage_image] =>[orig_patent_app_number] => 10793497
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/793497 | Compositions and methods for non-parenteral delivery of oligonucleotides | Mar 3, 2004 | Abandoned |
Array
(
[id] => 7316846
[patent_doc_number] => 20040224019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs'
[patent_app_type] => new
[patent_app_number] => 10/791989
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15102
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224019.pdf
[firstpage_image] =>[orig_patent_app_number] => 10791989
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/791989 | Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs | Mar 2, 2004 | Abandoned |
Array
(
[id] => 6437855
[patent_doc_number] => 20100144038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell'
[patent_app_type] => utility
[patent_app_number] => 10/594349
[patent_app_country] => US
[patent_app_date] => 2004-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31607
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144038.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594349 | Composition And Method For Increasing Efficiency Of Introduction Of Target Substance Into Cell | Mar 2, 2004 | Abandoned |
Array
(
[id] => 5672970
[patent_doc_number] => 20060178325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Modulation of growth hormone receptor expression and insulin-like growth factor expression'
[patent_app_type] => utility
[patent_app_number] => 10/547239
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28627
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547239
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547239 | Modulation of growth hormone receptor expression and insulin-like growth factor expression | Feb 26, 2004 | Issued |
Array
(
[id] => 7328728
[patent_doc_number] => 20040253723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Modulation of growth hormone receptor expression and insulin-like growth factor expression'
[patent_app_type] => new
[patent_app_number] => 10/789526
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28872
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789526 | Modulation of growth hormone receptor expression and insulin-like growth factor expression | Feb 25, 2004 | Issued |
Array
(
[id] => 5625259
[patent_doc_number] => 20060263764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Methods and constructs for evaluation of rnai targets and effector molecules'
[patent_app_type] => utility
[patent_app_number] => 10/547256
[patent_app_country] => US
[patent_app_date] => 2004-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6454
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547256 | Methods and constructs for evaluation of rnai targets and effector molecules | Feb 23, 2004 | Abandoned |
Array
(
[id] => 7011389
[patent_doc_number] => 20050065105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Modulation of APPL expression'
[patent_app_type] => utility
[patent_app_number] => 10/785168
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7631
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10785168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/785168 | Modulation of APPL expression | Feb 22, 2004 | Abandoned |
Array
(
[id] => 7432395
[patent_doc_number] => 20040162260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Reversible attachment of a membrane active polymer to a polynucleotide'
[patent_app_type] => new
[patent_app_number] => 10/780484
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7037
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162260.pdf
[firstpage_image] =>[orig_patent_app_number] => 10780484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/780484 | Reversible attachment of a membrane active polymer to a polynucleotide | Feb 16, 2004 | Issued |
Array
(
[id] => 7428347
[patent_doc_number] => 20040161799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'KOR3like-proteins and methods of modulating KOR3L-mediated activity'
[patent_app_type] => new
[patent_app_number] => 10/779104
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6847
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20040161799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10779104
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/779104 | KOR3like-proteins and methods of modulating KOR3L-mediated activity | Feb 12, 2004 | Abandoned |
Array
(
[id] => 7061024
[patent_doc_number] => 20050003385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Isolated DNA or gene responsible for Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/776604
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 13084
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003385.pdf
[firstpage_image] =>[orig_patent_app_number] => 10776604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/776604 | Isolated DNA or gene responsible for Parkinson's disease | Feb 11, 2004 | Abandoned |